Business Description
Siemens Healthineers AG
ISIN : DE000SHL1006
Share Class Description:
SEMHF: Registered SharesTotal Employee Number:
73,800Compare
Compare
Traded in other countries / regions
SHL.Germany0PMJ.UKSMMNY.USASHL.AustriaSHL.Bulgaria1SHL.ItalySHL N.Mexico IPO Date
2018-05-18Description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.69 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | 0.17 | |||||
Interest Coverage | 7.96 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 1.91 | |||||
Beneish M-Score | -2.53 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.6 | |||||
3-Year EBITDA Growth Rate | 2.5 | |||||
3-Year EPS without NRI Growth Rate | 1.8 | |||||
3-Year FCF Growth Rate | 18.1 | |||||
3-Year Book Growth Rate | -3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 13.36 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.44 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 66.18 | |||||
9-Day RSI | 69.54 | |||||
14-Day RSI | 66.38 | |||||
3-1 Month Momentum % | -2 | |||||
6-1 Month Momentum % | -22.05 | |||||
12-1 Month Momentum % | -29.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.16 | |||||
Quick Ratio | 0.79 | |||||
Cash Ratio | 0.21 | |||||
Days Inventory | 114.12 | |||||
Days Sales Outstanding | 71.02 | |||||
Days Payable | 57.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.59 | |||||
Dividend Payout Ratio | 0.51 | |||||
3-Year Dividend Growth Rate | 3.8 | |||||
Forward Dividend Yield % | 2.59 | |||||
5-Year Yield-on-Cost % | 3.2 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 3.01 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.02 | |||||
Operating Margin % | 13.99 | |||||
Net Margin % | 9.55 | |||||
EBITDA Margin % | 19.3 | |||||
FCF Margin % | 11.24 | |||||
OCF Margin % | 14.76 | |||||
ROE % | 12.09 | |||||
ROA % | 4.94 | |||||
ROIC % | 6.81 | |||||
3-Year ROIIC % | -4.71 | |||||
ROC (Joel Greenblatt) % | 69.19 | |||||
ROCE % | 10.37 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 20.1 | |||||
Forward PE Ratio | 16.17 | |||||
PE Ratio without NRI | 20.1 | |||||
Shiller PE Ratio | 21.4 | |||||
Price-to-Owner-Earnings | 13.26 | |||||
PEG Ratio | 3.14 | |||||
PS Ratio | 1.9 | |||||
PB Ratio | 2.28 | |||||
Price-to-Free-Cash-Flow | 16.77 | |||||
Price-to-Operating-Cash-Flow | 12.78 | |||||
EV-to-EBIT | 12.66 | |||||
EV-to-Forward-EBIT | 11.98 | |||||
EV-to-EBITDA | 9.34 | |||||
EV-to-Forward-EBITDA | 8.65 | |||||
EV-to-Revenue | 1.8 | |||||
EV-to-Forward-Revenue | 1.64 | |||||
EV-to-FCF | 16.04 | |||||
Price-to-GF-Value | 0.78 | |||||
Price-to-Projected-FCF | 1.16 | |||||
Price-to-DCF (Earnings Based) | 1.48 | |||||
Price-to-DCF (FCF Based) | 1.26 | |||||
Earnings Yield (Greenblatt) % | 7.9 | |||||
FCF Yield % | 5.96 | |||||
Forward Rate of Return (Yacktman) % | 9.31 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SEMHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Siemens Healthineers AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 26,952.742 | ||
| EPS (TTM) ($) | 2.289 | ||
| Beta | 0.7207 | ||
| 3-Year Sharpe Ratio | -0.49 | ||
| 3-Year Sortino Ratio | -0.62 | ||
| Volatility % | 21.38 | ||
| 14-Day RSI | 66.38 | ||
| 14-Day ATR ($) | 1.282152 | ||
| 20-Day SMA ($) | 42.404125 | ||
| 12-1 Month Momentum % | -29.77 | ||
| 52-Week Range ($) | 37 - 57.75 | ||
| Shares Outstanding (Mil) | 1,119.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Siemens Healthineers AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Siemens Healthineers AG Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| First quarter earnings conference call for 2027 | 2027-02-05 07:30 | In 179 days | ||
| First quarter earnings results for 2027 | 2027-02-05 07:00 | In 179 days | ||
| General meeting for 2027 | 2027-02-05 | In 178 days | ||
| Annual report for 2026 | 2026-11-26 | In 107 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-11-05 | In 86 days | ||
| Fourth quarter earnings results for 2026 | 2026-11-05 | In 86 days | ||
| Third quarter earnings conference call for 2026 | 2026-07-03 | 39.98 (-1.48%) | ||
| Third quarter earnings results for 2026 | 2026-07-03 | 39.98 (-1.48%) | ||
| Second quarter earnings conference call for 2026 | 2026-05-07 08:30 | 41.88 (+0.90%) | ||
| Second quarter earnings results for 2026 | 2026-05-07 | 41.88 (+0.90%) |
Show
Entries
Siemens Healthineers AG Frequently Asked Questions
What is Siemens Healthineers AG(SEMHF)'s stock price today?
The current price of SEMHF is $46.00. The 52 week high of SEMHF is $57.75 and 52 week low is $37.00.
When is next earnings date of Siemens Healthineers AG(SEMHF)?
The next earnings date of Siemens Healthineers AG(SEMHF) is 2026-11-05.
Does Siemens Healthineers AG(SEMHF) pay dividends? If so, how much?
The Dividend Yield %  of Siemens Healthineers AG(SEMHF) is 2.59% (As of Today), Highest Dividend Payout Ratio of Siemens Healthineers AG(SEMHF) was 0.71. The lowest was 0.45. And the median was 0.51. The  Forward Dividend Yield % of Siemens Healthineers AG(SEMHF) is 2.59%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on OTCPK:SEMHF
No articles.
Press Release
Articles on Siemens Healthineers AG
No articles.
Headlines
See More- 1
Jul 31, 2026
Siemens Healthineers Non-GAAP EPS of €0.70, revenue of €5.76B; updates FY 2026 outlook
Seeking Alpha • 2:51am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers